Catalog No.
PHD56301
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human CD238/KEL (Asn68-Ser280).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
Kell blood group glycoprotein,KEL,CD238
Purification
Purified by antigen affinity column.
Accession
P23276
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation., PMID:38804163
A novel KEL c.1414-1G>T allele in a polish patient with anti-Ku antibody., PMID:35932201
Novel KEL allele associated with loss of Kpb identified in a white blood donor., PMID:35852066
Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols., PMID:35191535
Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice., PMID:34249009
Novel KEL*02N allele in Saudi Arabia encoding a Kell null (K0 ) phenotype., PMID:34137046
HLA-DRB1 molecules and the presentation of anchor peptides from RhD, RhCE, and KEL proteins., PMID:33675036
Do red cell alloantibodies continue to challenge breast fed babies?, PMID:32083382
Establishment of KEL*01 and KEL*02 Genotyping to Recruit Uncommon, Kell-positive, Reagent Red Cells Among Thai Blood Donors., PMID:31625357
Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses., PMID:30429364
Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model., PMID:30418129
Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies., PMID:29445378
Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin., PMID:28871080
Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion., PMID:28250159
Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice., PMID:27688803
Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model., PMID:26950259
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells., PMID:26643781
NON-INVASIVE MONITORING OF FOETAL ANAEMIA IN KELL SENSITIZED PREGNANCY., PMID:26411147
Kell and Kx blood group systems., PMID:26308465
Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model., PMID:26185172
The prevalence of anti-K in Canadian prenatal patients., PMID:25968929
Molecular Basis of KELnull Phenotype in Brazilians., PMID:25960716
Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch., PMID:25175412
Associations of Rhesus and non-Rhesus maternal red blood cell alloimmunization with stillbirth and preterm birth., PMID:24801308
Intrauterine red cell transfusion for anti-Kell isoimmunization in a fetus with Glanzmann's thrombasthenia., PMID:23861189
[A KEL*02mod allele responsible for an apparent maternity exclusion]., PMID:23727116
For research use only. Not for human or drug use.
